Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBRAM.L Regulatory News (BRAM)

  • There is currently no data for BRAM

Form 8 (OPD) - Brammer plc

24 Nov 2016 11:03

Maitland Institutional Services Ltd - Form 8 (OPD) - Brammer plc

Maitland Institutional Services Ltd - Form 8 (OPD) - Brammer plc

PR Newswire

London, November 24

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Amendment made to Section 2

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:MI Chelverton UK Equity Income Fund
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.Chelverton Asset Management
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeBrammer plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure23 November 2016
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:Ordinary 20p shares
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:2,380,7661.84%
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:2,380,7661.84%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?No

Date of disclosure:24/11/2016
Contact name:George Bayer, Maitland Administration Services Limited, Corporate Secretary
Telephone number:01245398984

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
7th Aug 20153:46 pmRNSDirector/PDMR Shareholding
5th Aug 20154:53 pmRNSHolding(s) in Company
3rd Aug 201510:36 amRNSDirector/PDMR Shareholding
28th Jul 20157:00 amRNSInterim Results
6th Jul 20159:58 amRNSBlocklisting Interim Review
26th Jun 20154:49 pmRNSHolding(s) in Company
4th Jun 20153:27 pmRNSHolding(s) in Company
2nd Jun 201512:54 pmRNSHolding(s) in Company
22nd May 201511:05 amRNSHolding(s) in Company
21st May 20153:43 pmRNSDirector/PDMR Shareholding
20th May 20154:02 pmRNSDirector/PDMR Shareholding
19th May 201511:47 amRNSHolding(s) in Company
15th May 20152:28 pmRNSResult of AGM
15th May 20157:00 amRNSAGM Trading Update
30th Apr 20155:08 pmRNSGroup Refinancing
30th Apr 20154:51 pmRNSDirector Declaration
31st Mar 20154:03 pmRNSAnnual Financial Report
20th Mar 20153:40 pmRNSDirector/PDMR Shareholding
12th Mar 20154:50 pmRNSDirector Declaration
6th Mar 201511:28 amRNSHolding(s) in Company
4th Mar 201512:33 pmRNSDirector/PDMR Shareholding
27th Feb 20153:50 pmRNSDirector/PDMR Shareholding
17th Feb 20157:00 amRNSPreliminary Results
27th Jan 20155:30 pmRNSHolding(s) in Company
15th Jan 20154:58 pmRNSBlocklisting Interim Review
13th Jan 20159:12 amRNSNotice of Results
7th Jan 201510:48 amRNSHolding(s) in Company
23rd Dec 20143:23 pmRNSDirector/PDMR Shareholding
22nd Dec 201411:44 amRNSDirector/PDMR Shareholding
10th Dec 20144:08 pmRNSHolding(s) in Company
5th Dec 20141:04 pmRNSDirector/PDMR Shareholding
2nd Dec 20143:56 pmRNSDirector/PDMR Shareholding
18th Nov 201411:11 amRNSDirector/PDMR Shareholding
14th Nov 20148:05 amRNSHolding(s) in Company
12th Nov 20144:03 pmRNSDirector/PDMR Shareholding
7th Nov 20147:00 amRNSInterim Management Statement
7th Oct 20143:00 pmRNSTotal Voting Rights
24th Sep 20144:39 pmRNSDirector/PDMR Shareholding
19th Sep 20147:00 amRNSDirector/PDMR Shareholding
16th Sep 201411:24 amRNSDirector/PDMR Shareholding
8th Sep 201410:54 amRNSHolding(s) in Company
7th Aug 20143:27 pmRNSDirector/PDMR Shareholding
6th Aug 201411:45 amRNSDirector/PDMR Shareholding
31st Jul 201412:11 pmRNSBlocklisting Interim Review
29th Jul 20143:00 pmRNSDirector/PDMR Shareholding
29th Jul 20147:00 amRNSInterim Results
23rd Jul 20147:00 amRNSAppointment of Non-Executive Director
14th Jul 20141:36 pmRNSHolding(s) in Company
7th Jul 201411:10 amRNSNotice of Results
26th Jun 20142:05 pmRNSProposed consolidation of Coventry DC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.